Anti-Inflammatory Drugs Market Forecast Signals New Revenue Opportunities Through 2030
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Anti-Inflammatory Drugs Market Forecast: What Market Value Is Expected By 2030?
The market for anti-inflammatory drugs has seen robust expansion in recent times. It is projected to increase from $152.08 billion in 2025 to $168.74 billion in 2026, reflecting an 11.0% compound annual growth rate (CAGR). This historical growth has been driven by factors such as the prevalence of arthritis, widespread use of NSAIDs, prescribing patterns in hospitals, the burden of autoimmune diseases, and the adoption of steroid therapies.
The anti-inflammatory drugs market is projected to experience significant expansion in the coming years, reaching a valuation of $252.87 billion by 2030, driven by a compound annual growth rate (CAGR) of 10.6 percentage points. During the forecast period, this growth is fueled by factors such as innovations in biologic therapies, the increasing penetration of biosimilars, an aging global population, the rising prevalence of autoimmune conditions, and a growing emphasis on precision medicine. Key trends shaping this market include a heightened utilization of biologics and biosimilars, an expansion in the treatment of chronic inflammatory diseases, a transition toward more targeted anti-inflammatory approaches, a surge in topical and localized formulations, and a greater focus on ensuring long-term safety profiles.
Download A Free Sample Report For Comprehensive Market Insights:
#Anti-Inflammatory Drugs Market Growth Factors: Which Forces Are Supporting Market Expansion?
The growing occurrence of arthritis is anticipated to fuel the expansion of the market for anti-inflammatory medications in the coming period. Arthritis is defined as the swelling of one or more joints, accompanied by discomfort, puffiness, and rigidity that may intensify over time. This increase in arthritis cases is largely driven by aging demographics, as advancing age leads to greater joint deterioration from natural use, raising the likelihood of contracting the condition. These drugs assist in controlling arthritis by alleviating joint swelling and pain, enabling patients to sustain improved movement and carry out everyday tasks with less difficulty, thereby enhancing their overall life quality. In July 2024, data from Restored CDC, a nonprofit health organization based in the United States, indicated that roughly 21.2% of American adults 18 years and older had been diagnosed with the condition during 2023. As a result, the heightened incidence of arthritis is pushing forward the expansion of the anti-inflammatory drug sector.
Anti-Inflammatory Drugs Market Categorization By Product Type And Application
The anti-inflammatory drugs market covered in this report is segmented –
1) By Drug Class: Steroids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Biologics And Biosimilars, Other Drug Classes
2) By Route of Administration: Parenteral, Oral, Topical, Inhalation
3) By Applications: Autoimmune Diseases, Respiratory Diseases, Other Diseases
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Steroids: Corticosteroids, Mineralocorticoids
2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Selective Cyclooxygenase-2 (COX-2) Inhibitors
3) By Biologics And Biosimilars: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin (IL) Inhibitors, Janus Kinase (JAK) Inhibitors, Other Biologics And Biosimilars
4) By Other Drug Classes: Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
Anti-Inflammatory Drugs Market Industry Trends: What Changes Are Reshaping Demand?
Leading market players in the anti-inflammatory drugs sector are channeling efforts into creating pioneering therapies, particularly advanced corticosteroid alternatives, to fulfill the increasing need for safer, long-term anti-inflammatory treatments. A cutting-edge corticosteroid alternative represents a therapeutic approach engineered to preserve the glucocorticoid-mediated anti-inflammatory benefits while mitigating common side effects of traditional steroids, such as bone density reduction, hindered growth, and increased body weight. In October 2023, for example, Santhera Pharmaceuticals, a specialty pharmaceutical firm headquartered in Switzerland, obtained FDA approval in the United States for AGAMREE (vamorolone). This oral dissociative steroid is formulated to provide anti-inflammatory effects while minimizing steroid-associated adverse events, achieved through selective modulation of glucocorticoid receptor pathways and the stabilization of cell membranes. When compared to conventional corticosteroids like prednisone and deflazacort, it exhibits an improved safety profile without compromising therapeutic efficacy. The medication is indicated for managing chronic muscle inflammation in children aged two years and older suffering from Duchenne muscular dystrophy.
Anti-Inflammatory Drugs Market Company Landscape And Strategic Competition
Major companies operating in the anti-inflammatory drugs market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited
Access The Complete Anti-Inflammatory Drugs Market Report:
Anti-Inflammatory Drugs Market Largest Region By Revenue And Market Share
North America was the largest region in the anti-inflammatory drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
